Login

Seattle Tech Hub Attracts Latest Injection of Biotech Investment

Planned Development Is Second Life Science Play for Blackstone’s BioMed
BioMed, Blackstone's life science arm, is planning another project in South Lake Union, acquiring a two-parcel portfolio at 2300 Seventh Ave. in Seattle’s longtime tech industry nerve center. (CoStar)
BioMed, Blackstone's life science arm, is planning another project in South Lake Union, acquiring a two-parcel portfolio at 2300 Seventh Ave. in Seattle’s longtime tech industry nerve center. (CoStar)
CoStar News
April 18, 2022 | 8:38 P.M.

BioMed Realty, the life science arm of New York-based Blackstone, is planning another project in South Lake Union, assembling two parcels in the latest injection of biotech investment into Seattle’s longtime tech industry nerve center.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

IN THIS ARTICLE